Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone–Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone–Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist

Published:2024-01 Issue:1 Volume:211 Page:63-70
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Crawford E. David¹,Hafron Jason M.²,Debruyne Frans³,Wallis Christopher⁴,Chang Steven⁵,Garnick Marc B.⁶

Affiliation:

1. University of California San Diego, Koman Family Outpatient Pavilion, San Diego, California

2. Michigan Institute of Urology, Troy, Michigan

3. Andros Clinics, Arnhem, The Netherlands

4. University of Toronto, Toronto, Ontario, Canada

5. Xelay Acumen Group, Inc, San Mateo, California

6. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003721

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular risk in ADT recipients: does the type of ADT matter?;Prostate Cancer and Prostatic Diseases;2024-04-25

2. Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone–Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist;Journal of Urology;2024-03

3. Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer;Current Oncology Reports;2024-02-20

4. Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology;Frontiers in Oncology;2024-01-31

5. Letter: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone‒Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist;Journal of Urology;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3